Posted by Site Administrator on June 11, 2012
Saneron will use the cells for future clinical trials to study possible therapies for restoring brain tissue in patients suffering from Alzheimer’s disease, amyotrophic lateral sclerosis (ALS), also known as “Lou Gehrig’s disease,” and the effects of stroke.
Categories: Uncategorized
|
Tags: 501(c)(3) ALS charity, ALS, ALS community, ALS medical care, ALS research funding, ALS treatments, amyotrophic lateral sclerosis, Bob Stehlin, GenCure, Inc., Lou Gehrig's disease, Mary Beth Fisk, Nicole Kuzmin-Nichols, RASCALS Foundation, Robert A. Stehlin Campaign for ALS, Saneron CCEL Therapeutics, South Texas Blood & Tissue Center, St.Louis RASCALS ALS Lou Gehrig’s Disease amotrophic lateral sclerosis, U-CORD-CELL™
|
No comments